仙琚制药：关于醋酸地塞米松片通过一致性评价的公告

Core Viewpoint - Xianju Pharmaceutical has received approval from the National Medical Products Administration for its Acetate Dexamethasone Tablets, indicating successful consistency evaluation of quality and efficacy for generic drugs [1] Group 1 - The company announced the receipt of the approval notice for the drug supplement application for Acetate Dexamethasone Tablets [1] - The approval notice is identified by the number 2025B03820 [1] - The drug has passed the consistency evaluation for quality and efficacy as a generic medication [1]